Inventor

KYM PHILIP R

US59 patents

⚠️ This page may combine multiple inventors who share the name “KYM PHILIP R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KYM PHILIP R

ABBOTT LAB

Glucocortiocoid-selective antinflammatory agents

Potassium channel openers

2-Aminoquinolines as melanin concentrating hormone receptor antagonists

Thienopyridones as AMPK activators for the treatment of diabetes and obesity

Glucocorticoid receptor antagonists for treatment of diabetes

Glucocorticoid receptor antagonists for treatment of diabetes

TRPV1 antagonists

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

Amide derivatives as TRPV1 antagonists

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

Potassium channel openers

Antagonists of melanin concentrating hormone receptor

Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor

ABBVIE SARL

Modulators of cystic fibrosis transmembrane conductance regulator protein

Heteroaryl substituted pyridines and methods of use

Substituted pyrrolidines and methods of use

N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use

Substituted pyrrolidines and methods of use

Heteroaryl substituted pyridines and methods of use

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

ABBVIE INC

Carbidopa and L-dopa prodrugs and methods of use

Carbidopa prodrug

Methods of treating Parkinson&#39;s disease

Carbidopa and L-dopa prodrugs and methods of use

TRPV3 modulators

TRPV3 modulators

TRPV1 antagonists

ABBVIE OVERSEAS SARL

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use

ABBVIE S Á R L

Substituted chromanes and method of use

Substituted tetrahydropyrans and method of use

CALICO LIFE SCIENCES LLC

Protein tyrosine phosphatase inhibitors and methods of use thereof

Protein tyrosine phosphatase inhibitors and methods of use thereof

JUDD ANDREW S

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

LIU GANG

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

KAROBIO AB

Glucocorticoid receptor ligands for the treatment of metabolic disorders

Glucocorticoid receptor ligands for the treatment of metabolic disorders

SOUERS ANDREW J

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

ABBVIE S À R L

Substituted tricyclics and method of use

GOMTSYAN ARTHUR R

TRPV1 antagonists

ABBVIE S ÀR L

Substituted pyrazolo[3,4-b]pyridin-6-carboxylic acids and method of use

LIGAND PHARM INC

Glucocorticoid-selective anti-inflammatory agents

Methods of treating Parkinson's disease